Pharmacogenomics studies how human genetic information impacts drug response. Rapid advances in our understanding of this area mean we now know that genetic differences between individuals can affect everything from the drug or drug class most likely to provide benefit to the likelihood of drug toxicity.

Intervenants: James M. Beck Matthew D. Jacobson

Type d’évènement: Formation juridique continue, Webinar

Date/heure de début
5 April 2018, 3:00 PM EDT
Date/heure de fin
5 April 2018, 4:00 PM EDT
This webinar will discuss how pharmacogenomics is already affecting product liability litigation and what further impact could be just around the corner.